Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2014 | 10-2013 | 10-2012 | 11-2011 | 10-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 362 | 339 | 583 | 76 | 76 |
| Receivables | 107 | 124 | 112 | 95 | 95 |
| Inventories | 118 | 87 | 77 | 17 | 17 |
| Other current assets | 13 | 0 | 0 | 0 | 0 |
| TOTAL | $603 | $625 | $834 | $187 | $187 |
| Non-Current Assets | |||||
| PPE Net | 179 | 1 | 1 | 0 | 0 |
| TOTAL | $179 | $1 | $1 | $0 | $0 |
| Total Assets | $782 | $626 | $836 | $188 | $188 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 126 | 126 |
| Accounts payable and accrued liabilities | 37 | 26 | 13 | 33 | 47 |
| Accrued Expenses | 17 | 15 | 14 | 14 | N/A |
| TOTAL | $123 | $56 | $72 | $191 | $191 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 133 | 133 |
| Deferred Revenues | 66 | 15 | 36 | 0 | N/A |
| TOTAL | $0 | $0 | $0 | $133 | $133 |
| Total Liabilities | $123 | $56 | $72 | $324 | $324 |
| Shareholders' Equity | |||||
| Retained earnings | -3,270 | -3,357 | -3,163 | -3,075 | -3,075 |
| Other shareholders' equity | 36 | 35 | 35 | 35 | 0 |
| TOTAL | $659 | $570 | $763 | $-137 | $-137 |
| Total Liabilities And Equity | $782 | $626 | $836 | $188 | $188 |